AstraZeneca
AZN
AZN
665 hedge funds and large institutions have $22.7B invested in AstraZeneca in 2020 Q2 according to their latest regulatory filings, with 114 funds opening new positions, 215 increasing their positions, 211 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
665
Holders Change
+65
Holders Change %
+10.83%
% of All Funds
13.67%
Holding in Top 10
11
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-15.38%
% of All Funds
0.23%
New
114
Increased
215
Reduced
211
Closed
48
Calls
$349M
Puts
$128M
Net Calls
+$221M
Net Calls Change
+$223M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$141M |
| 2 |
Morgan Stanley
New York
|
+$80.5M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$80M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$66.2M |
| 5 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$66.1M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$678M |
| 2 |
Dodge & Cox
San Francisco,
California
|
-$587M |
| 3 |
Primecap Management
Pasadena,
California
|
-$158M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$44.9M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$32.2M |
